4. Bergeron DE, Cessna JT, Zimmerman BE. Two determinations of the Ge-68 half-life. Appl Radiat Isot. 2018 Apr;134:416-420. \[[PMC free article: PMC6236682](/pmc/articles/PMC6236682/)\] \[[PubMed: 29100721](https://pubmed.ncbi.nlm.nih.gov/29100721)\] 5. Taqueti VR, Di Carli MF. Radionuclide myocardial perfusion imaging for the evaluation of patients with known or suspected coronary artery disease in the era of multimodality cardiovascular imaging. Prog Cardiovasc Dis. 2015 May-Jun;57(6):644-53. \[[PMC free article: PMC5926794](/pmc/articles/PMC5926794/)\] \[[PubMed: 25770849](https://pubmed.ncbi.nlm.nih.gov/25770849)\] 6. Chan SY, Brunken RC, Czernin J, Porenta G, Kuhle W, Krivokapich J, Phelps ME, Schelbert HR. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol. 1992 Oct;20(4):979-85. \[[PubMed: 1527310](https://pubmed.ncbi.nlm.nih.gov/1527310)\] 7. Reiss AB, Grossfeld D, Kasselman LJ, Renna HA, Vernice NA, Drewes W, Konig J, Carsons SE, DeLeon J. Adenosine and the Cardiovascular System. Am J Cardiovasc Drugs. 2019 Oct;19(5):449-464. \[[PMC free article: PMC6773474](/pmc/articles/PMC6773474/)\] \[[PubMed: 30972618](https://pubmed.ncbi.nlm.nih.gov/30972618)\] 8. Bokhari S, Ficaro EP, McCallister BD. Adenosine stress protocols for myocardial perfusion imaging. J Nucl Cardiol. 2007 May-Jun;14(3):415-6. \[[PubMed: 17556176](https://pubmed.ncbi.nlm.nih.gov/17556176)\] 9. Stolker JM, Lim MJ, Shavelle DM, Morris DL, Angiolillo DJ, Guzman LA, Kennedy KF, Weber E, Zareh M, Neumayr RH, Zenni MM. Pooled comparison of regadenoson versus adenosine for measuring fractional flow reserve and coronary flow in the catheterization laboratory. Cardiovasc Revasc Med. 2015 Jul-Aug;16(5):266-71. \[[PubMed: 26242981](https://pubmed.ncbi.nlm.nih.gov/26242981)\] 10. Skopicki HA, Abraham SA, Picard MH, Alpert NM, Fischman AJ, Gewirtz H. Effects of dobutamine at maximally tolerated dose on myocardial blood flow in humans with ischemic heart disease. Circulation. 1997 Nov 18;96(10):3346-52. \[[PubMed: 9396426](https://pubmed.ncbi.nlm.nih.gov/9396426)\] 11. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006 Nov;3(11):e442. \[[PMC free article: PMC1664601](/pmc/articles/PMC1664601/)\] \[[PubMed: 17132052](https://pubmed.ncbi.nlm.nih.gov/17132052)\] 12. Buttar HS, Li T, Ravi N. Prevention of cardiovascular diseases: Role of exercise, dietary interventions, obesity and smoking cessation. Exp Clin Cardiol. 2005 Winter;10(4):229-49. \[[PMC free article: PMC2716237](/pmc/articles/PMC2716237/)\] \[[PubMed: 19641674](https://pubmed.ncbi.nlm.nih.gov/19641674)\] 13. Gaziano TA. Reducing the growing burden of cardiovascular disease in the developing world. Health Aff (Millwood). 2007 Jan-Feb;26(1):13-24. \[[PMC free article: PMC2365905](/pmc/articles/PMC2365905/)\] \[[PubMed: 17211010](https://pubmed.ncbi.nlm.nih.gov/17211010)\] **Disclosure:** Shwetha Gopal declares no relevant financial relationships with ineligible companies. **Disclosure:** Christie Murphy declares no relevant financial relationships with ineligible companies.